We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
Location: United Kingdom
Total raised: $5.82M
Investors 1
| Date | Name | Website |
| 20.06.2025 | Empirical ... | empiricalv... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 13.01.2026 | Seed | $3.37M | Kadmos Cap... |
| 24.06.2025 | Seed | $2.45M | - |
Mentions in press and media 8
| Date | Title | Description |
| 14.01.2026 | OutSee Secures £2.5M, Propels AI Genomics for Drug Discovery | OutSee secured a significant £2.5M seed funding round. Ahren Innovation Capital spearheaded the investment. This capital fuels OutSee's groundbreaking AI-powered Nomaly platform. Nomaly uses a "genomics-first" approach. It predict... |
| 13.01.2026 | OutSee Closes £2.5M Seed Funding Round | OutSee, a Cambridge, England-based developer of an AI-based predictive genomics approach to target discovery, raised £2.5M in seed funding. The round was led by Ahren Innovation Capital, with participation from Kadmos Capital, Panacea, Empi... |
| 12.01.2026 | OutSee: £2.5 Million Seed Round Completed And Partnership With o2h Discovery | OutSee, an AI-enabled genomics and drug discovery company, has closed a £2.5 million seed funding round and signed a strategic agreement with o2h discovery to begin a collaborative drug discovery programme around OutSee’s lead drug target c... |
| 25.06.2025 | OutSee Secures £1.8M Seed Funding to Revolutionize Drug Discovery | In the world of genomics and drug discovery, innovation is the lifeblood. OutSee, a Cambridge-based company, has just injected new energy into this field by securing £1.8 million in seed funding. This financial boost, led by Ahren Innovatio... |
| 24.06.2025 | OutSee raises £1.8M to expand therapeutic pipeline using predictive genomics | Cambridge-based OutSee has secured £1.8 million in seed funding. The company has previously received over £500,000 in precision medicine grants from Innovate UK to support technology extensions and to test their application on dementia case... |
| 24.06.2025 | OutSee Raises £1.8M in Seed Funding | OutSee, a Cambridge, UK-based genomics and drug discovery company, raised £1.8M in Seed funding. The round wads led by Ahren Innovation Capital and with investment from Kadmos Capital, Empirical Ventures and Panacea Ventures. The company in... |
| 24.06.2025 | OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics | Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea Ventures Investment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and pro... |
| - | OutSee | “We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...” |